학술논문

Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed
Document Type
Article
Source
In: Thoracic Cancer. (Thoracic Cancer, September 2023, 14(25):2567-2578)
Subject
Language
English
ISSN
17597714
17597706